相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors
Charlotte Charpentier et al.
AIDS (2010)
The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates
Maria Jose Buzon et al.
AIDS (2010)
Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo
Olivier Delelis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Role of the 207-218 peptide region of Moloney murine leukemia virus integrase in enzyme catalysis
Monica L. Acevedo et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Biochemical and Pharmacological Analyses of HIV-1 Integrase Flexible Loop Mutants Resistant to Raltegravir
Mathieu Metifiot et al.
BIOCHEMISTRY (2010)
New therapeutic strategies for raltegravir
Carolina Garrido et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens
Daniel da Silva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir
Filippo Canducci et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Solution Conformation and Dynamics of the HIV-1 Integrase Core Domain
Nicholas C. Fitzkee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Activity of Elvitegravir, a Once-Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose-Ranging Clinical Trial
Andrew R. Zolopa et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Early Emergence of Raltegravir Resistance Mutations in Patients Receiving HAART Salvage Regimens
Fausto Baldanti et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Analysis of the Viral Elements Required in the Nuclear Import of HIV-1 DNA
Lise Riviere et al.
JOURNAL OF VIROLOGY (2010)
Retroviral intasome assembly and inhibition of DNA strand transfer
Stephen Hare et al.
NATURE (2010)
HIV-1 Integrase Inhibitors: 2007-2008 Update
Kavya Ramkumar et al.
MEDICINAL RESEARCH REVIEWS (2010)
Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome
Ila R. Singh et al.
PLOS ONE (2010)
Targeting HIV-1 DNA integration by swapping tethers
Robert Craigie
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration
Andrea L. Ferris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The dynamics of appearance and disappearance of HIV-1 integrase mutations during and after withdrawal of raltegravir therapy
Ruth Bridget Ferns et al.
AIDS (2009)
Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure
Signe Fransen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase Inhibitors
Andrea Low et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics
Koichiro Nakahara et al.
ANTIVIRAL RESEARCH (2009)
Implications of HIV-1 M Group Polymorphisms on Integrase Inhibitor Efficacy and Resistance: Genetic and Structural in Silico Analyses
Eriketi Z. Loizidou et al.
BIOCHEMISTRY (2009)
Therapeutic Potential of Peptide Motifs Against HIV-1 Reverse Transcriptase and Integrase
M. L. Andreola
CURRENT PHARMACEUTICAL DESIGN (2009)
HIV-1 IN Inhibitors: 2010 Update and Perspectives
Christophe Marchand et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Retroviral integrase superfamily: the structural perspective
Marcin Nowotny
EMBO REPORTS (2009)
The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals
Jennifer Cocohoba
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
49th ICAAC Annual Meeting: optimization of anti-infective use in the clinical setting
Rosa F Yeh et al.
Expert Review of Anti-Infective Therapy (2009)
Piecing together the structure of retroviral integrase, an important target in AIDS therapy
Mariusz Jaskolski et al.
FEBS JOURNAL (2009)
Lack of Primary Mutations Associated With Integrase Inhibitors Among HIV-1 Subtypes B, C, and F Circulating in Brazil
Caroline Bittencourt-Passaes et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients
Isabelle Malet et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Evolution of raltegravir resistance during therapy
Nadine Sichtig et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways
Signe Fransen et al.
JOURNAL OF VIROLOGY (2009)
Selective-Advantage Profile of Human Immunodeficiency Virus Type 1 Integrase Mutants Explains In Vivo Evolution of Raltegravir Resistance Genotypes
Romina Quercia et al.
JOURNAL OF VIROLOGY (2009)
Raltegravir: a new choice in HIV and new chances for research
Sean Emery et al.
LANCET (2009)
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Jeffrey L. Lennox et al.
LANCET (2009)
The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation
Olivier Delelis et al.
NUCLEIC ACIDS RESEARCH (2009)
Functional and structural characterization of the integrase from the prototype foamy virus
Eugene Valkov et al.
NUCLEIC ACIDS RESEARCH (2009)
Augmentation of Reverse Transcription by Integrase through an Interaction with Host Factor, SIP1/Gemin2 Is Critical for HIV-1 Infection
Hironori Nishitsuji et al.
PLOS ONE (2009)
Raltegravir, elvitegravir, and metoogravir: the birth of me-too HIV-1 integrase inhibitors
Erik Serrao et al.
RETROVIROLOGY (2009)
Mechanisms of human immunodeficiency virus type 1 concerted integration related to strand transfer inhibition and drug resistance
Jacob A. Zahm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137
Anneleen Hombrouck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro
Isabelle Malet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants
Masanori Kobayashi et al.
ANTIVIRAL RESEARCH (2008)
Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants
Jessica Marinello et al.
BIOCHEMISTRY (2008)
Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy
C. Charpentier et al.
HIV MEDICINE (2008)
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors
Ira B. Dicker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors
Olivia Goethals et al.
JOURNAL OF VIROLOGY (2008)
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection
David A. Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Integrase inhibitors: A new treatment option for patients with human immunodeficiency virus infection
Todd Correll et al.
PHARMACOTHERAPY (2008)
Integrase and integration: biochemical activities of HIV-1 integrase
Olivier Delelis et al.
RETROVIROLOGY (2008)
The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication
Alan Engelman et al.
PLOS PATHOGENS (2008)
Broad Antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)
Kazuya Shimura et al.
JOURNAL OF VIROLOGY (2008)
Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors
Ira B. Dicker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Rapid and durable Antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection - Results of a 48-week controlled study
Martin Markowitz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Single-particle image reconstruction of a tetramer of HIV integrase bound to DNA
Gang Ren et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients
Edwin DeJesus et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat ends
AP Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cellular co-factors of HIV-1 integration
B Van Maele et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Integration requires a specific interaction of the donor DNA terminal 5′-cytosine with glutamine 148 of the HIV-1 integrase flexible loop
AA Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
P Cherepanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A three-dimensional model of the human immunodeficiency virus type 1 integration complex
J Wielens et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2005)
Integrase inhibitors to treat HIV/AIDS
Y Pommier et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type I integrase
R Lu et al.
JOURNAL OF VIROLOGY (2005)
HIV-1 integrase crosslinked oligomers are active in vitro
A Faure et al.
NUCLEIC ACIDS RESEARCH (2005)
Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions
ES Svarovskaia et al.
JOURNAL OF VIROLOGY (2004)
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase
DJ Hazuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques
DJ Hazuda et al.
SCIENCE (2004)
Human immunodeficiency virus type 1 (HIV-1) integrase: Resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to L-chicoric acid
DJ Lee et al.
JOURNAL OF VIROLOGY (2004)
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360
V Fikkert et al.
AIDS (2004)
Structure and function of HIV-1 integrase
TK Chiu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Development of resistance against Diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations
V Fikkert et al.
JOURNAL OF VIROLOGY (2003)
Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors
PJ King et al.
VIROLOGY (2003)
Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes
JA Grobler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein
JY Wang et al.
EMBO JOURNAL (2001)
Structure-activity of inhibition of HIV-1 integrase and virus replication by G-quartet oligonucleotides
NJ Jing et al.
DNA AND CELL BIOLOGY (2001)
Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding
JCH Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells
N Tsurutani et al.
JOURNAL OF VIROLOGY (2000)
Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
DJ Hazuda et al.
SCIENCE (2000)
分享论文
